Parikh, A. S., Li, Y., Mazul, A., Yu, V. X., Thorstad, W., Rich, J., Paniello, R. C., Caruana, S. M., Troob, S. H., Jackson, R. S., Pipkorn, P., Zolkind, P., Qi, Z., Adkins, D., Ding, L., & Puram, S. V. (2023). Immune Cell Deconvolution Reveals Possible Association of γδ T Cells with Poor Survival in Head and Neck Squamous Cell Carcinoma. Cancers, 15(19), 4855. https://doi.org/10.3390/cancers15194855

O’Neil, D. S., Ayeni, O. A., Farrow, H. A., Chen, W. C., Demetriou, G., Buccimazza, I., Čačala, S., Stopforth, L. W., Joffe, M., Antoni, M. H., Lopes, G., Pumpalova, Y. S., Mapanga, W., Jacobson, J. S., Crew, K. D., Neugut, A. I., Ruff, P., & Cubasch, H. (2023). The Impact of HIV Infection on Neoadjuvant and Adjuvant Chemotherapy Relative Dose Intensity in South African Patients with Breast Cancer. The Oncologist, 28(10), e921–e929. https://doi.org/10.1093/oncolo/oyad056

Grafova, I. B., Manne, S. L., Hudson, S. V., Elliott, J., Llanos, A. A. M., Saraiya, B., & Duberstein, P. R. (2023). Functional impairment is associated with medical debt in male cancer survivors and credit card debt in female cancer survivors. Supportive Care in Cancer, 31(10). https://doi.org/10.1007/s00520-023-08070-1

Kehm, R. D., Lilge, L., Walter, E. J., White, M., Herbstman, J. B., Perera, F. P., Miller, R. L., Terry, M. B., & Tehranifar, P. (2023). Socioeconomic Status at Birth and Breast Tissue Composition in Adolescence and Adulthood. Cancer Epidemiology, Biomarkers & Prevention, 32(10), 1294–1301. https://doi.org/10.1158/1055-9965.epi-23-0444

Garden, A. S., Harris, J., Eisbruch, A., Chao, K. S. C., Morrison, W. H., Harari, P. M., Swanson, T. A., Jones, C. U., Yom, S. S., Spencer, S. A., Scrimger, R., Shenouda, G., Shukla, M., Lau, H. Y., Mierzwa, M., Torres-Saavedra, P., & Le, Q. T. (2023). Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer. International Journal of Radiation Oncology*Biology*Physics, 117(2), 333–340. https://doi.org/10.1016/j.ijrobp.2023.02.057

Lamanna, N., Tam, C., Jurczak, W., Kontos, A., Konig, H., Ruppert, A., Tsai, D., & Scheliga, A. (2023). COMPARISON OF BLEEDING-RELATED EVENTS IN PATIENTS WHO RECEIVED PIRTOBRUTINIB WITH AND WITHOUT ANTITHROMBOTIC AGENTS. Hematology, Transfusion and Cell Therapy, 45, S161. https://doi.org/10.1016/j.htct.2023.09.359

Searle, B. C., Chien, A., Koller, A., Hawke, D., Herren, A. W., Kim Kim, J., Lee, K. A., Leib, R. D., Nelson, A. J., Patel, P., Ren, J. M., Stemmer, P. M., Zhu, Y., Neely, B. A., & Patel, B. (2023). A Multipathway Phosphopeptide Standard for Rapid Phosphoproteomics Assay Development. Molecular & Cellular Proteomics, 22(10), 100639. https://doi.org/10.1016/j.mcpro.2023.100639

Ferris, J. S., Morgan, D. A., Tseng, A. S., Terry, M. B., Ottman, R., Hur, C., Wright, J. D., & Genkinger, J. M. (2023). Risk factors for developing both primary breast and primary ovarian cancer: A systematic review. Critical Reviews in Oncology/Hematology, 190, 104081. https://doi.org/10.1016/j.critrevonc.2023.104081

Houghton, L. C., Paniagua‐Avila, A., Hua, S., Terry, M. B., McDonald, J. A., Ulanday, K. T., van Horn, L., Carnethon, M. R., & Isasi, C. R. (2023). Immigrant generation status and its association with pubertal timing and tempo among Hispanic girls and boys. American Journal of Human Biology, 35(10). Portico. https://doi.org/10.1002/ajhb.23940

Patel, S., Mckean, M., Piperno-Neumann, S., Shoushtari, A. N., Hernandez-Aya, L., Orloff, M., Khan, S., Montazeri, K., Kapiteijn, E., Buchbinder, E., Agresta, S., Reilly, S., Patriquin, C. M., Hickman, D., Corrigan, D., Granlund, L., Hentemann, M., Piel, J., Martin, P., & Mehmi, I. (2023). 1128P A phase I dose escalation and expansion study of FHD-286, a novel BRG1/BRM (SMARCA4/SMARCA2) inhibitor, for the treatment of metastatic uveal melanoma. Annals of Oncology, 34, S677–S678. https://doi.org/10.1016/j.annonc.2023.09.2262

Baruchel, A., Bourquin, J.-P., Crispino, J., Cuartero, S., Hasle, H., Hitzler, J., Klusmann, J.-H., Izraeli, S., Lane, A. A., Malinge, S., Rabin, K. R., Roberts, I., Ryeom, S., Tasian, S. K., & Wagenblast, E. (2023). Down syndrome and leukemia: from basic mechanisms to clinical advances. Haematologica, 108(10), 2570–2581. https://doi.org/10.3324/haematol.2023.283225

Mckean, M., Chmielowski, B., Butler, M. O., Carvajal, R., Rodon, J., Carlino, M., Kim, K. B., Wise-draper, T., Khan, S., Salama, A. K. S., Moser, J., Reeves, J., Wilner, K. D., Maurer, M., Abed, M., Mitchell, B., Beaupre, D., & Orloff, M. (2023). 1081O ctDNA reduction and clinical efficacy of the darovasertib + crizotinib (daro + crizo) combination in metastatic uveal melanoma (MUM). Annals of Oncology, 34, S651. https://doi.org/10.1016/j.annonc.2023.09.2215

Kokossis, D., Wei, H. J., Gallitto, M., Yoh, N., McQuillan, N., Tazhibi, M., Berg, X., Zhang, X., Szalontay, L., Gartrell, R., Jovana, P., Zhang, Z., Molotkov, A., Mintz, A., Konofagou, E. E., & Wu, C. C. (2023). Focused Ultrasound for Blood-Brain Barrier Opening and Delivery of Anti-PD1 in Diffuse Midline Gliomas. International Journal of Radiation Oncology*Biology*Physics, 117(2), e523–e524. https://doi.org/10.1016/j.ijrobp.2023.06.1796

Tavakol, D. N., Nash, T. R., Kim, Y., He, S., Fleischer, S., Graney, P. L., Brown, J. A., Liberman, M., Tamargo, M., Harken, A., Ferrando, A. A., Amundson, S., Garty, G., Azizi, E., Leong, K. W., Brenner, D. J., & Vunjak-Novakovic, G. (2023). Modeling and countering the effects of cosmic radiation using bioengineered human tissues. Biomaterials, 301, 122267. https://doi.org/10.1016/j.biomaterials.2023.122267

Wen, P. Y., van den Bent, M., Youssef, G., Cloughesy, T. F., Ellingson, B. M., Weller, M., Galanis, E., Barboriak, D. P., de Groot, J., Gilbert, M. R., Huang, R., Lassman, A. B., Mehta, M., Molinaro, A. M., Preusser, M., Rahman, R., Shankar, L. K., Stupp, R., Villanueva-Meyer, J. E., … Chang, S. M. (2023). RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. Journal of Clinical Oncology, 41(33), 5187–5199. https://doi.org/10.1200/jco.23.01059

Liu, Y., Reiken, S., Dridi, H., Yuan, Q., Mohammad, K. S., Trivedi, T., Miotto, M. C., Wedderburn-Pugh, K., Sittenfeld, L., Kerley, Y., Meyer, J. A., Peters, J. S., Persohn, S. C., Bedwell, A. A., Figueiredo, L. L., Suresh, S., She, Y., Soni, R. K., Territo, P. R., … Guise, T. A. (2023). Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice. Science Translational Medicine, 15(715). https://doi.org/10.1126/scitranslmed.adf8977

Johnson, M., Bell, A., Lauing, K. L., Ladomersky, E., Zhai, L., Penco-Campillo, M., Shah, Y., Mauer, E., Xiu, J., Nicolaides, T., Drumm, M., McCortney, K., Elemento, O., Kim, M., Bommi, P., Low, J. T., Memon, R., Wu, J., Zhao, J., … Wainwright, D. A. (2023). Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral Influence. Clinical Cancer Research, 29(23), 4973–4989. https://doi.org/10.1158/1078-0432.ccr-23-0834

Qunaj, L., May, M. S., Neugut, A. I., & Herzberg, B. O. (2023). Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal cancer. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1252516

Li, C., Furth, E. E., Rustgi, A. K., & Klein, P. S. (2023). When You Come to a Fork in the Road, Take It: Wnt Signaling Activates Multiple Pathways through the APC/Axin/GSK-3 Complex. Cells, 12(18), 2256. https://doi.org/10.3390/cells12182256

Doshi, S. D., DeStephano, D., Accordino, M. K., Elkin, E., Raghunathan, R. R., Wright, J. D., & Hershman, D. L. (2023). Disparities with influenza vaccine use in long-term survivors of metastatic breast cancer. Breast Cancer Research and Treatment, 203(1), 111–119. https://doi.org/10.1007/s10549-023-07109-5

Neugut, A. I., & Bates, S. E. (2023). Highlights of ASCO 2023. The Oncologist, 28(9), 739–742. https://doi.org/10.1093/oncolo/oyad222

Irajizad, E., Kenney, A., Tang, T., Vykoukal, J., Wu, R., Murage, E., Dennison, J. B., Sans, M., Long, J. P., Loftus, M., Chabot, J. A., Kluger, M. D., Kastrinos, F., Brais, L., Babic, A., Jajoo, K., Lee, L. S., Clancy, T. E., Ng, K., … Fahrmann, J. F. (2023). A blood-based metabolomic signature predictive of risk for pancreatic cancer. Cell Reports Medicine, 4(9), 101194. https://doi.org/10.1016/j.xcrm.2023.101194

Kambhampati, A., Meghani, K., Ndlovu, N., Monare, B., Mutimuri, M., Bazzett-Matabele, L., Vuylsteke, P., Ketlametswe, R., Ralefala, T., Neugut, A. I., Jacobson, J. S., Vulpe, H., & Grover, S. (2023). A Multi-Institutional Study of Barriers to Cervical Cancer Care in Sub-Saharan Africa. Advances in Radiation Oncology, 8(5), 101257. https://doi.org/10.1016/j.adro.2023.101257

Flynn, J. R., Curry, M., Zhao, B., Yang, H., Dercle, L., Fojo, A. T., Connors, D. E., Schwartz, L. H., Gönen, M., & Moskowitz, C. S. (2023). Modeling Tumor Growth Using Partly Conditional Survival Models: A Case Study in Colorectal Cancer. JCO Clinical Cancer Informatics, 7. https://doi.org/10.1200/cci.22.00203

Parsons, S. K., Beauchemin, M. P., Dupuis, L., Sugalski, A., Wolfson, J. A., Santacroce, S. J., Marchak, J. G., Sung, L., & Roth, M. E. (2023). Children’s Oncology Group 2023 blueprint for research: Cancer care delivery research. Pediatric Blood & Cancer, 70(S6). Portico. https://doi.org/10.1002/pbc.30579

Laszkowska, M., Zhang, X., Kuliszewski, M. G., Hur, C., Lim, F., Rogers, A., & Xinhui Tan, S. (2023). Heightened Risk for Gastric Cancer Among Immigrant Populations in New York State From High-Incidence Countries. Clinical Gastroenterology and Hepatology, 21(10), 2673-2675.e3. https://doi.org/10.1016/j.cgh.2022.08.008

VanderVeer, E., Huang, S. J. T., Bruyere, H., Li, C., Ramadan, K., Villa, D., Scott, D. W., Savage, K. J., Connors, J. M., Sehn, L. H., Toze, C. L., & Gerrie, A. S. (2023). POSTER: CLL-617 Long Term Outcomes and Secondary Malignancies in 673 Patients Treated With Oral Fludarabine and Intravenous Rituximab (FR) for Chronic Lymphocytic Leukemia (CLL) in British Columbia (BC), CanadaElys. Clinical Lymphoma Myeloma and Leukemia, 23, S173. https://doi.org/10.1016/s2152-2650(23)00531-1

Ager, C. R., Zhang, M., Chaimowitz, M., Bansal, S., Tagore, S., Obradovic, A., Jugler, C., Rogava, M., Melms, J. C., McCann, P., Spina, C., Drake, C. G., Dallos, M. C., & Izar, B. (2023). KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response. Journal for ImmunoTherapy of Cancer, 11(9), e006782. https://doi.org/10.1136/jitc-2023-006782

Muehlenbein, C. E., Coombs, C. C., Shah, N. N., Jurczak, W., Woyach, J., Cheah, C. Y., Patel, K., Maddocks, K., Wang, Y., Wang, C., Abhyankar, S., Tsai, D. E., & Eyre, T. A. (2023). POSTER: CT-166 Long-Term Safety With ≥12 Months of Pirtobrutinib in Relapsed/Refractory B-Cell Malignancies. Clinical Lymphoma Myeloma and Leukemia, 23, S229. https://doi.org/10.1016/s2152-2650(23)00883-2

Ko, K.-P., Huang, Y., Zhang, S., Zou, G., Kim, B., Zhang, J., Jun, S., Martin, C., Dunbar, K. J., Efe, G., Rustgi, A. K., Nakagawa, H., & Park, J.-I. (2023). Key Genetic Determinants Driving Esophageal Squamous Cell Carcinoma Initiation and Immune Evasion. Gastroenterology, 165(3), 613-628.e20. https://doi.org/10.1053/j.gastro.2023.05.030

Schreidah, C. M., Reynolds, G. B., Fahmy, L. M., Carvajal, R. D., Vermeer, M. H., Whittaker, S., Pe’er, I., & Geskin, L. J. (2023). Scoping review of genetic databases for rare dermatologic diseases: Opportunity for artificial intelligence and machine learning. JAAD International, 12, 24–31. https://doi.org/10.1016/j.jdin.2023.02.017

Schlenk, R. F., Montesinos, P., Romero-Aguilar, A., Vrhovac, R., Patkowska, E., Kim, H.-J., Zak, P., Wang, P.-N., Hanyok, J., Liu, L., Kamel, Y. M., Lesegretain, A., Cortes, J., Sekeres, M. A., Dombret, H., Amadori, S., Wang, J., Perl, A. E., Levis, M. J., & Erba, H. P. (2023). POSTER: CT-186 Impact of Allogeneic Hematopoietic Cell Transplantation (allo-HCT) in First Complete Remission (CR1) in Addition to FLT3 Inhibition With Quizartinib in Acute Myeloid Leukemia (AML) With FLT3–Internal Tandem Duplication (FLT3-ITD): Results from the QuANTUM-First Trial. Clinical Lymphoma Myeloma and Leukemia, 23, S229. https://doi.org/10.1016/s2152-2650(23)00885-6

Konig, H., Tam, C. S., Lamanna, N., Jurczak, W., Kontos, A., Ruppert, A. S., & Tsai, D. E. (2023). POSTER: CT-168 Comparison of Bleeding-Related Events in Patients Who Received Pirtobrutinib With and Without Antithrombotic Agents. Clinical Lymphoma Myeloma and Leukemia, 23, S229. https://doi.org/10.1016/s2152-2650(23)00884-4

Winestone, L. E., Beauchemin, M. P., Bona, K., Kahn, J., Prasad, P., Robles, J. M., & Velez, M. C. (2023). Children’s Oncology Group’s 2023 blueprint for research: Diversity and health disparities. Pediatric Blood & Cancer, 70(S6). Portico. https://doi.org/10.1002/pbc.30592

Terry, M. B., & Colditz, G. A. (2023). Epidemiology and Risk Factors for Breast Cancer: 21st Century Advances, Gaps to Address through Interdisciplinary Science. Cold Spring Harbor Perspectives in Medicine, 13(9), a041317. https://doi.org/10.1101/cshperspect.a041317

Zhang, L., Zhang, J., Xuan, X., Wu, D., Yu, J., Wang, P., Yang, X., Zhang, J., Gan, W., He, M., Liu, X.-M., Zhou, J., Wang, D., Gu, W., & Li, D. (2023). A p53/LINC00324 positive feedback loop suppresses tumor growth by counteracting SET-mediated transcriptional repression. Cell Reports, 42(8), 112833. https://doi.org/10.1016/j.celrep.2023.112833

Chen, J., Zhang, W., Wang, Y., & Yang, W. (2023). Determinants of measles persistence in Beijing, China: A modelling study. Epidemiology and Infection, 151. https://doi.org/10.1017/s0950268823001322

Lichtiger, L., Jezioro, J., Rivera, J., McDonald, J. D., Terry, M. B., Sahay, D., & Miller, R. L. (2023). Prenatal airborne polycyclic aromatic hydrocarbon exposure, altered regulation of peroxisome proliferator-activated receptor gamma (Ppar)γ, and links with mammary cancer. Environmental Research, 231, 116213. https://doi.org/10.1016/j.envres.2023.116213

Thomas, J. F., Valencia-Sánchez, M. I., Tamburri, S., Gloor, S. L., Rustichelli, S., Godínez-López, V., De Ioannes, P., Lee, R., Abini-Agbomson, S., Gretarsson, K., Burg, J. M., Hickman, A. R., Sun, L., Gopinath, S., Taylor, H. F., Sun, Z.-W., Ezell, R. J., Vaidya, A., Meiners, M. J., … Armache, K.-J. (2023). Structural basis of histone H2A lysine 119 deubiquitination by Polycomb repressive deubiquitinase BAP1/ASXL1. Science Advances, 9(32). https://doi.org/10.1126/sciadv.adg9832

Chakraborty, R., Al Hadidi, S., Scheffer Cliff, E. R., & Mohyuddin, G. R. (2023). Is aggressive treatment of smoldering myeloma the path to curing myeloma? Blood Advances, 7(15), 3932–3935. https://doi.org/10.1182/bloodadvances.2023009658

Yang, X., Wang, Z., Zandkarimi, F., Liu, Y., Duan, S., Li, Z., Kon, N., Zhang, Z., Jiang, X., Stockwell, B. R., & Gu, W. (2023). Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism. Cell Metabolism, 35(8), 1474-1490.e8. https://doi.org/10.1016/j.cmet.2023.06.014

Feng, J., Hsu, P.-F., Esteva, E., Labella, R., Wang, Y., Khodadadi-Jamayran, A., Pucella, J., Liu, C. Z., Arbini, A. A., Tsirigos, A., Kousteni, S., & Reizis, B. (2023). Haplodeficiency of the 9p21 tumor suppressor locus causes myeloid disorders driven by the bone marrow microenvironment. Blood, 142(5), 460–476. https://doi.org/10.1182/blood.2022018512

Goel, N., Rhim, A. D., Xi, H., Olive, K. P., Thomas, A. S., Kwon, W., Schwartz, J., Sugahara, K. N., Schrope, B. A., Chabot, J. A., & Kluger, M. D. (2022). Transfusion of salvaged red blood cells during pancreatic ductal adenocarcinoma operations. British Journal of Surgery, 110(8), 917–919. https://doi.org/10.1093/bjs/znac393

Brown, J. R., Eichhorst, B., Ghia, P., Jurczak, W., Kahl, B., Lamanna, N., Robak, T., Shadman, M., Tam, C., Qiu, L., Cohen, A., Zhang, M., Salmi, T., Paik, J., Wang, L., Zhang, J., MA, H., & Tedeschi, A. (2023). P631: CHARACTERIZATION OF ZANUBRUTINIB SAFETY/TOLERABILITY PROFILE AND COMPARISON WITH IBRUTINIB PROFILE IN PATIENTS WITH B-CELL MALIGNANCIES: POST HOC ANALYSIS OF A LARGE CLINICAL TRIAL SAFETY DATABASE. HemaSphere, 7(S3), e356884b. https://doi.org/10.1097/01.hs9.0000969428.35688.4b

Manji, G. A., Labadie, B. W., Lee, S. M., Pellicciotta, I., Ge, L., Sta Ana, S., Sender, N., Ross, I., Wong, W., & Raufi, A. G. (2023). MEKiAUTO: A multicenter phase 1 study of combination therapy with the MEK inhibitor, cobimetinib, immune checkpoint blockade, atezolizumab, and the autophagy inhibitor hydroxychloroquine (HCQ) in KRAS-mutated advanced malignancies. JCO Global Oncology, 9(Supplement_1), 45–45. https://doi.org/10.1200/go.2023.9.supplement_1.45

Rillamas-Sun, E., Kwan, M. L., Iribarren, C., Cheng, R., Neugebauer, R., Rana, J. S., Nguyen-Huynh, M., Shi, Z., Laurent, C. A., Lee, V. S., Roh, J. M., Huang, Y., Shen, H., Hershman, D. L., Kushi, L. H., & Greenlee, H. (2023). Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Breast Cancer Research and Treatment, 201(1), 117–126. https://doi.org/10.1007/s10549-023-06997-x

Locatelli, F., Lang, P., Corbacioglu, S., LI, A., De La Fuente, J., Wall, D., Meisel, R., Shah, A. J., Liem, R., Mapara, M., Carpenter, B., Kwiatkowski, J., Domenica Cappellini, M., Kattamis, A., Sheth, S., Grupp, S., Kohli, P., Shi, D., Ross, L., … Frangoul, H. (2023). S270: TRANSFUSION INDEPENDENCE AFTER EXAGAMGLOGENE AUTOTEMCEL IN PATIENTS WITH TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA. HemaSphere, 7(S3), e8473180. https://doi.org/10.1097/01.hs9.0000967992.84731.80

Eichhorst, B., Lamanna, N., O’brien, S., Tam, C., Qiu, L., Yang, K., Wu, K., Salmi, T., Barnes, G., & Brown, J. R. (2023). P640: ZANUBRUTINIB VS IBRUTINIB IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL LYMPHOCYTIC LYMPHOMA (R/R CLL/SLL): IMPACT ON HEALTH-RELATED QUALITY OF LIFE (HRQOL). HemaSphere, 7(S3), e02428b9. https://doi.org/10.1097/01.hs9.0000969464.02428.b9

Phakathi, B., Dix-Peek, T., Van Den Berg, E., Dickens, C., Nietz, S., Cubasch, H., Joffe, M., Neugut, A. I., Jacobson, J. S., Ruff, P., & Duarte, R. (2023). PAM50 intrinsic subtypes, risk of recurrence score and breast cancer survival in HIV-positive and HIV-negative patients—a South African cohort study. Breast Cancer Research and Treatment, 200(3), 337–346. https://doi.org/10.1007/s10549-023-06969-1

Rustgi, S. D., Zylberberg, H. M., Hur, C., & Shah, S. C. (2023). Management of Gastric Intestinal Metaplasia. Clinical Gastroenterology and Hepatology, 21(9), 2178–2182. https://doi.org/10.1016/j.cgh.2023.03.010